Experts are recommending greater use of telemedicine in stroke assessment and treatment. There are significant barriers, however, many imposed by government.
A recent Kaiser Foundation data note looks at attitudes on paying for health reform.
Expensive cancer drugs may not enhance outcomes for many people, raising questions about covering their use.
A recent JAMA commentary gives a concise summary of the cost control problems.
A study reported in the current issue of NEJM indicates that enrollment in Part D significantly increased drug spending for those persons who previously had no or a low level of drug coverage, but also led to a lower level of medical spending.
Massachusetts residents are not thrilled with their health care reform, according to a Rasmussen poll.